FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

THYROCARE

707.9
+4.9 (0.7%)
Updated 10:37 13/08 IST

THYROCARE Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for THYROCARE
Disclaimer
0% Bullish
0% Bearish

THYROCARE Buy or Sell - Brokerage Reports

No. of reports in last year
6
No. of analysts
2
Average Consensus Forecast
524.17
Consensus Potential
-51.56%
See THYROCARE Share Price Targets >>

THYROCARE Ratings

Long term THYROCARE rating by FrontPage users
5/5 (3 Ratings)
Find answers to all your questions on live THYROCARE message board: Is THYROCARE buy or sell? Should I buy THYROCARE shares? Why are THYROCARE shares falling? Should I invest in THYROCARE stock?

  1. Home
  2. THYROCARE Forum

THYROCARE Share Price Discussion

N
Reputation: 192 • Aug 10 5:06 AM

Type
Buy
Instrument
THYROCARE
Entry Price
₹696
Price@Trade
₹695.2
Target Price
₹706
Stop Price
₹686
Valid Till
Aug 17, 2020 3:20 AM
Margin
₹69,600 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
CRUDEOIL 19AUG20 FUT
Entry Price
₹3,134
Price@Trade
₹3,134
Target Price
₹3,240
Stop Price
₹3,107
Valid Till
Aug 19, 2020 11:20 AM
Margin
₹313,418.75 approx for 100 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 27AUG20 FUT
Entry Price
₹22,036
Price@Trade
₹22,030
Target Price
₹22,200
Stop Price
₹22,000
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹124,542.9 approx for 25 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
BANKNIFTY 13AUG20 22000 PE
Entry Price
₹305
Price@Trade
₹307.6
Target Price
₹475
Stop Price
₹275
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹7,625,000 approx for 25000 Qty
Status
Waiting for entry
Like
Reply
N
Reputation: 4,769 • Aug 10 5:06 AM
Share market update: Media shares advance; DB Corp jumps 5%
The Nifty Media index was trading 0.36 per cent up at 1340.8.
The Economic Times
Like
Reply
N
Reputation: 192 • Aug 10 5:06 AM

Type
Buy
Instrument
NAVINFLUOR
Entry Price
₹2,050
Price@Trade
₹2,050
Target Price
₹2,100
Stop Price
₹2,000
Valid Till
Aug 17, 2020 3:20 AM
Margin
₹102,500 approx for 50 Qty
Status
Active
Like
Reply
J
Reputation: 666 • Aug 10 5:05 AM

Type
Buy
Instrument
NIFTY 27AUG20 FUT
Entry Price
₹11,329
Price@Trade
₹11,329
Target Price
₹11,361
Stop Price
₹11,300
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹147,464.6 approx for 75 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
MCDOWELL-N
Entry Price
₹599
Price@Trade
₹597.05
Target Price
₹625
Stop Price
₹587
Valid Till
Aug 17, 2020 3:20 AM
Margin
₹59,900 approx for 100 Qty
Status
Waiting for entry
Like
Reply
P
Reputation: 6,989 • Aug 10 5:05 AM

Type
Buy
Instrument
IGL AUG20 400 CE
Entry Price
₹11.5
Price@Trade
₹11.5
Target Price
₹20
Stop Price
₹5
Valid Till
Aug 27, 2020 3:20 AM
Margin
₹158,125 approx for 13750 Qty
Status
Active
Like
Reply
N
Reputation: 192 • Aug 10 5:05 AM

Type
Buy
Instrument
VARROC
Entry Price
₹225
Price@Trade
₹225.8
Target Price
₹235
Stop Price
₹215
Valid Till
Aug 17, 2020 3:20 AM
Margin
₹22,500 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
BANKNIFTY 13AUG20 21700 PE
Entry Price
₹100
Price@Trade
₹184.95
Target Price
₹400
Stop Price
₹10
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹2,500 approx for 25 Qty
Status
Waiting for entry
Like
Reply

Type
Sell
Instrument
BAJFINANCE
Entry Price
₹3,485.45
Price@Trade
₹3,485.45
Target Price
₹3,354.5
Stop Price
₹3,547.25
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹97,592.6 approx for 28 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
ARIES
Entry Price
₹70
Price@Trade
₹71.65
Target Price
₹72
Stop Price
₹68
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹7,000 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
GRASIM AUG20 FUT
Entry Price
₹634.2
Price@Trade
₹633.4
Target Price
₹639.5
Stop Price
₹629.2
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹256,452.05 approx for 950 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Debasish @debasish-B1DjROIWv
Aug 10 5:03 AM

Update
Exited before entry
Price @ Update
₹633.4

Type
Sell
Instrument
BAJFINANCE
Entry Price
₹3,488.35
Price@Trade
₹3,488.35
Target Price
₹3,355.05
Stop Price
₹3,547.8
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹97,673.8 approx for 28 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
UPL
Entry Price
₹492.9
Price@Trade
₹492.9
Target Price
₹525
Stop Price
₹484
Valid Till
Sep 10, 2020 3:20 AM
Margin
₹49,290 approx for 100 Qty
Status
Active
Like
Reply
S
Reputation: 1,527 • Aug 10 5:02 AM

10-08-20
TCS BUY AUG CE 2320 (Intraday)
only above @ 73.30
Like
Reply

Type
Buy
Instrument
BANKNIFTY 13AUG20 22200 CE
Entry Price
₹224
Price@Trade
₹230.4
Target Price
₹320
Stop Price
₹180
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹4,480,000 approx for 20000 Qty
Status
Waiting for entry
Like
Reply
S
Reputation: 5,519 • Aug 10 5:02 AM
soni in NTPC
Trade entered: Buy NTPC AUG20 85 CE @2.85 Targe...

Go long even if you buy now...August shd give you the #NTPC profits
Like
Reply

Type
Sell
Instrument
SILVERM 31AUG20 FUT
Entry Price
₹75,500
Price@Trade
₹75,494
Target Price
₹70,000
Stop Price
₹80,000
Valid Till
Aug 31, 2020 11:20 AM
Margin
₹200,770.5 approx for 15 Qty
Status
Active
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Aug 10 5:02 AM

Update
Trade Entered
Entry Price
₹75,500
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • THYROCARE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,801.04
    Enterprise Value2,791.99
    Price to Earnings33.64
    Price to Book Value6.14
    Return on Capital Employed0.33
    Return on Equity0.21
    Face Value10
    Dividend Yield0.02
  • THYROCARE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    4-Aug-20Prabhudas LilladherSell307
    27-May-20Prabhudas LilladherSell307
    4-Feb-20Prabhudas LilladherBuy724
    8-Nov-19Prabhudas LilladherBuy686
    22-Aug-19Karvy Stock BrokingBuy526
    THYROCARE Brokerage Price Target
  • THYROCARE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 12700720686703
    Aug 11715719700704.45
    Aug 10701720688.05712.6
    Aug 7704.95710.05697699.95
    Aug 6688706676.45700.8
  • THYROCARE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹660.51
    30 Day Moving Average₹619.47
    50 Day Moving Average₹579.69
    100 Day Moving Average₹547.74
    200 Day Moving Average₹553.8
  • THYROCARE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue332300.060.11
    Operating Profit137117.210.17
    Profit Before Tax148113.30.31
    Net Income9674.850.28
  • THYROCARE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4564540
    Total Liabilities3234-0.06
    Total Assets488488NA
  • THYROCARE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity11289.270.25
    Cash from Investing Activity-48-39.650.21
    Cash from Financing Activity-65-48.50.34
    Net Cash Flow-11.11-1.9
  • THYROCARE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.20.17
    Return on Equity0.210.18
    Return on Capital Employed0.330.27
  • THYROCARE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.84
    3 Year CAGR Growth in Operating Profit0.83
    3 Year CAGR Growth in EBIDTA0.91
    3 Year CAGR Growth in Net Income0.95
    3 Yr CAGR Growth - Diluted EPS0.83
  • THYROCARE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.47
    5 Year CAGR Growth in Operating Profit1.16
    5 Year CAGR Growth in EBIDTA0.98
    5 Year CAGR Growth in Net Income0.69
    3 Yr CAGR Growth - Diluted EPS-0.66
  • THYROCARE - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 8 6:13 AM
    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Jul 21 4:58 AM
    Coronavirus in India | COVID-19 widespread but 18 crore Indians may already have immunity says Thyrocare's antibody tests
    Moneycontrol
    NewsBot
    Jul 21 12:41 PM
    Virus may be widespread, but not too lethal, indicate antibody tests at private labs
    The Economic Times
    NewsBot
    Jul 3 3:38 AM
    Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests'
    Moneycontrol
    NewsBot
    May 27 5:08 AM
    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Apr 9 11:53 AM
    Free COVID-19 tests: Private labs cry foul, say need government support
    Moneycontrol
    NewsBot
    Mar 28 1:33 AM
    Practo ties up with Thyrocare to offer bookings of COVID-19 test on its platform
    Moneycontrol
    NewsBot
    Mar 18 4:58 AM
    Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing
    Moneycontrol
    NewsBot
    Feb 3 1:43 AM
    Stocks in the news: M&M, Maruti, Coal India, Tata Motors, Alkem Labs, Indian Bank
    Moneycontrol
    NewsBot
    Sep 23, 2019 1:58 AM
    Stocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent Pharma
    Moneycontrol
  • THYROCARE - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020